Scientific Articles

Neil Riordan Article Count: 55 – Updated March 9, 2011

  • Increased Level of Circulating Endothelial Microparticles and Cardiovascular Risk Factors. J Clinic Experiment Cardiol. 2011 April 5;2:131. [Abstract]

    • Mirikova N, Casciari J, Hunninghake R, Riordan N.

  • Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med. 2011 Mar 4;9(1):25. [Abstract]

    • Ichim TE, Minev B, Braciak T, Luna B, Hunninghake R, Mikirova NA, Jackson JA, Gonzalez MJ, Miranda Massari JR, Alexandrescu DT, Dasanu C, Bogin V, Ancans J, Stevens RB, Markosian B, Koropatnick J, Chen CS, Riordan NH.

  • On the missing link between inflammation and cancer. Dermatol Online J. 2011 Jan 15;17(1):10. [Abstract]

    • Alexandrescu DT, Riordan NH, Ichim TE, Kauffman CL, Kabigting F, Dutton CT, Dasanu CA.

  • Cutaneous sarcoidosis and malignancy: An association between sarcoidosis with skin manifestations and systemic neoplasia. Dermatol Online J. 2011 Jan 15;17(1):2. [Abstract]

    • Alexandrescu DT, Kauffman CL, Ichim TE, Riordan NH, Kabigting F, Dasanu CA.

  • Outstanding survival and regeneration process by the use of intelligent acellular dermal matrices and mesenchymal stem cells in a burn pig model. Transplant Proc. 2010 Dec;42(10):4275-8. [Abstract]

    • Mansilla E, Spretz R, Larsen G, Nuñez L, Drago H, Sturla F, Marin GH, Roque G, Martire K, Díaz Aquino V, Bossi S, Gardiner C, Lamonega R, Lauzada N, Cordone J, Raimondi JC, Tau JM, Biasi NR, Marini JE, Patel AN, Ichim TE, Riordan N, Maceira A.

  • Prevention of hyperglycemia-induced myocardial apoptosis by gene silencing of Toll-like receptor-4. J Transl Med. 2010 Dec 15;8:133. [Abstract]

    • Zhang Y, Peng T, Zhu H, Zheng X, Zhang X, Jiang N, Cheng X, Lai X, Shunnar A, Singh M, Riordan N, Bogin V, Tong N, Min WP.

  • Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report. Int Arch Med. 2010 Nov 11;3:30. [Abstract]

    • Ichim TE, Solano F, Lara F, Paris E, Ugalde F, Rodriguez JP, Minev B, Bogin V, Ramos F, Woods EJ, Murphy MP, Patel AN, Harman RJ, Riordan NH.

  • Vitamin D concentrations, endothelial progenitor cells, and cardiovascular risk factors. Panminerva Med. 2010 Jun;52(2 Suppl 1):81-7. [Abstract]

    • Mikirova NA, Belcaro G, Jackson JA, Riordan NH.

  • Circulating endothelial progenitor cells and erectile dysfunction: possibility of nutritional intervention? Panminerva Med. 2010 Jun;52(2 Suppl 1):75-80. [Abstract]

    • Ichim TE, Zhong Z, Mikirova NA, Jackson JA, Hunninghake R, Mansilla E, Marín G, Núñez L, Patel AN, Angle N, Murphy MP, Dasanu CA, Alexandrescu DT, Bogin V, Riordan NH.

  • Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions. J Transl Med. 2010 Aug 3;8:75. [Abstract]

    • Yang WZ, Zhang Y, Wu F, Min WP, Minev B, Zhang M, Luo XL, Ramos F, Ichim TE, Riordan NH, Hu X.

  • Immunotherapy for melanoma: current status and perspectives. J Immunother. 2010 Jul-Aug;33(6):570-90. [Abstract]

    • Alexandrescu DT, Ichim TE, Riordan NH, Marincola FM, Di Nardo A, Kabigting FD, Dasanu CA.

  • Autologous stromal vascular fraction cells: a tool for facilitating tolerance in rheumatic disease. Cell Immunol. 2010;264(1):7-17. Epub 2010 Apr 8. [Abstract]

    • Ichim TE, Harman RJ, Min WP, Minev B, Solano F, Rodriguez JP, Alexandrescu DT, DeNecochea-Campion R, Hu X, Marleau AM, Riordan NH.

  • Tumor vaccines in 2010: need for integration. Cell Immunol. 2010;263(2):138-47. Epub 2010 Apr 3. [Abstract]

    • Koos D, Josephs SF, Alexandrescu DT, Chan RC, Ramos F, Bogin V, Gammill V, Dasanu CA, De Necochea-Campion R, Riordan NH, Carrier E.

  • Combination stem cell therapy for heart failure. Int Arch Med. 2010 Apr 14;3(1):5. [Abstract]

    • Ichim TE, Solano F, Lara F, Rodriguez JP, Cristea O, Minev B, Ramos F, Woods EJ, Murphy MP, Alexandrescu DT, Patel AN, Riordan NH.

  • Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects. J Transl Med. 2010 Apr 8;8:34. [Abstract]

    • Mikirova NA, Jackson JA, Hunninghake R, Kenyon J, Chan KW, Swindlehurst CA, Minev B, Patel AN, Murphy MP, Smith L, Ramos F, Ichim TE, Riordan NH.

  • The lysosomotropic agent, hydroxychloroquine, delivered in a biodegradable nanoparticle system, overcomes drug resistance of B-chronic lymphocytic leukemia cells in vitro. Cancer Biother Radiopharm. 2010 Feb;25(1):97-103. [Abstract]

    • Mansilla E, Marin GH, Nuñez L, Drago H, Sturla F, Mertz C, Rivera L, Ichim T, Riordan N, Raimondi C.

  • The next generation of burns treatment: intelligent films and matrix, controlled enzymatic debridement, and adult stem cells. Transplant Proc. 2010 Jan-Feb;42(1):345-9. [Abstract]

    • Drago H, Marín GH, Sturla F, Roque G, Mártire K, Díaz Aquino V, Lamonega R, Gardiner C, Ichim T, Riordan N, Raimondi JC, Bossi S, Samadikuchaksaraei A, van Leeuwen M, Tau JM, Núñez L, Larsen G, Spretz R, Mansilla E.

  • Ascorbate inhibition of angiogenesis in aortic rings ex vivo and subcutaneous Matrigel plugs in vivo. J Angiogenes Res. 2010 Jan 18;2:2. [Abstract]

    • Mikirova NA, Casciari JJ, Riordan NH.

  • Circulating endothelial progenitor cells: a new approach to anti-aging medicine? J Transl Med. 2009 Dec 15;7:106. [Abstract]

    • Mikirova NA, Jackson JA, Hunninghake R, Kenyon J, Chan KW, Swindlehurst CA, Minev B, Patel AN, Murphy MP, Smith L, Alexandrescu DT, Ichim TE, Riordan NH.

  • Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. Cell Immunol. 2010;260(2):75-82. [Abstract]

    • Ichim TE, Alexandrescu DT, Solano F, Lara F, Campion Rde N, Paris E, Woods EJ, Murphy MP, Dasanu CA, Patel AN, Marleau AM, Leal A, Riordan NH.

  • Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med. 2009 Apr 24;7:29.[Abstract]

    • Riordan NH, Ichim TE, Min WP, Wang H, Solano F, Lara F, Alfaro M, Rodriguez JP, Harman RJ, Patel AN, Murphy MP, Lee RR, Minev B.

  • Feasibility investigation of allogeneic endometrial regenerative cells. J Transl Med. 2009 Feb 20;7:15. [Abstract]

    • Zhong Z, Patel AN, Ichim TE, Riordan NH, Wang H, Min WP, Woods EJ, Reid M, Mansilla E, Marin GH, Drago H, Murphy MP, Minev B.

  • Inhibition of intracranial glioma growth by endometrial regenerative cells. Cell Cycle. 2009 Feb 15;8(4):606-10. Epub 2009 Mar 2. [Abstract]

    • Han X, Meng X, Yin Z, Rogers A, Zhong J, Rillema P, Jackson JA, Ichim TE, Minev B, Carrier E, Patel AN, Murphy MP, Min WP, Riordan NH.

  • Anti-angiogenic effect of high doses of ascorbic acid. J Transl Med. 2008 Sep 12;6:50. [Abstract]

    • Mikirova NA, Ichim TE, Riordan NH.

  • Allogeneic endometrial regenerative cells: an “Off the shelf solution” for critical limb ischemia? J Transl Med. 2008 Aug 19;6:45. [Abstract]

    • Murphy MP, Wang H, Patel AN, Kambhampati S, Angle N, Chan K, Marleau AM, Pyszniak A, Carrier E, Ichim TE, Riordan NH.

  • Granulocyte activity in patients with cancer and healthy subjects. Cancer Biol Ther. 2008 Sep;7(9):1362-7. Epub 2008 Sep 2. [Abstract]

    • Mikirova NA, Klykov AA, Jackson JA, Riordan NH.

  • Exosomes as a tumor immune escape mechanism: possible therapeutic implications. J Transl Med. 2008 Jul 22;6:37. [Abstract]

    • Ichim TE, Zhong Z, Kaushal S, Zheng X, Ren X, Hao X, Joyce JA, Hanley HH, Riordan NH, Koropatnick J, Bogin V, Minev BR, Min WP, Tullis RH.

  • Immune effects of mesenchymal stem cells: implications for Charcot-Marie-Tooth disease. Cell Immunol. 2008 May-Jun;253(1-2):11-5. Epub 2008 Jul 15. [Abstract]

    • Leal A, Ichim TE, Marleau AM, Lara F, Kaushal S, Riordan NH.

  • Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy. Reprod Biomed Online. 2008 Jun;16(6):898-905. [Abstract]

    • Ichim TE, Solano F, Brenes R, Glenn E, Chang J, Chan K, Riordan NH.

  • Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate. P R Health Sci J. 2008 Mar;27(1):7-19. [Abstract]

    • Duconge J, Miranda-Massari JR, Gonzalez MJ, Jackson JA, Warnock W, Riordan NH.

  • Antigen-specific therapy of rheumatoid arthritis. Expert Opin Biol Ther. 2008 Feb;8(2):191-9. [Abstract]

    • Ichim TE, Zheng X, Suzuki M, Kubo N, Zhang X, Min LR, Beduhn ME, Riordan NH, Inman RD, Min WP.

  • Endometrial regenerative cells: a novel stem cell population. J Transl Med. 2007 Nov 15;5:57. [Abstract]

    • Meng X, Ichim TE, Zhong J, Rogers A, Yin Z, Jackson J, Wang H, Ge W, Bogin V, Chan KW, Thébaud B, Riordan NH.

  • Stem cell therapy for autism. J Transl Med. 2007 Jun 27;5:30. [Abstract]

    • Ichim TE, Solano F, Glenn E, Morales F, Smith L, Zabrecky G, Riordan NH.

  • Vitamin C pharmacokinetics after continuous infusion in a patient with prostate cancer. Ann Pharmacother. 2007 Jun;41(6):1082-3. Epub 2007 May 22. [Abstract]

    • Duconge J, Miranda-Massari JR, González MJ, Taylor PR, Riordan HD, Riordan NH, Casciari JJ, Alliston K.

  • Cord blood in regenerative medicine: do we need immune suppression? J Transl Med. 2007 Jan 30;5:8. [Abstract]

    • Riordan NH, Chan K, Marleau AM, Ichim TE.

  • Therapeutic use of Aldara in chronic myeloid leukemia. J Transl Med. 2007 Jan 25;5:4. [Abstract]

    • Marleau AM, Lipton JH, Riordan NH, Ichim TE.

  • Tumor growth parameters of in-vivo human breast carcinoma: a proposed mathematical model for tumor growth kinetics. P R Health Sci J. 2006 Mar;25(1):71-3. [Abstract]

    • González MJ, Herrera FL, Miranda-Massari JM, Guzmán AM, Riordan NH, Ricart CM.

  • Induction of antitumor immunity through xenoplacental immunization. J Transl Med. 2006 May 25;4:22. [Abstract]

    • Zhong Z, Kusznieruk KP, Popov IA, Riordan NH, Izadi H, Yijian L, Sher S, Szczurko OM, Agadjanyan MG, Tullis RH, Harandi A, Reznik BN, Mamikonyan GV, Ichim TE.

  • A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. P R Health Sci J. 2005 Dec;24(4):269-76. [Abstract]

    • Riordan HD, Casciari JJ, González MJ, Riordan NH, Miranda-Massari JR, Taylor P, Jackson JA.

  • A novel method of modifying immune responses by vaccination with lipiodol-siRNA mixtures. J Transl Med. 2006 Jan 3;4:2. [Abstract]

    • Ichim TE, Popov IA, Riordan NH, Izadi H, Zhong Z, Yijian L, Sher S, Oleinik EK.

  • Cancer is a functional repair tissue. Med Hypotheses. 2006;66(3):486-90. Epub 2005 Nov 15. [Abstract]

    • Meng X, Riordan NH.

  • Orthomolecular oncology review: ascorbic acid and cancer 25 years later. Integr Cancer Ther. 2005 Mar;4(1):32-44. [Abstract]

    • González MJ, Miranda-Massari JR, Mora EM, Guzmán A, Riordan NH, Riordan HD, Casciari JJ, Jackson JA, Román-Franco A.

  • Intravenous vitamin C as a chemotherapy agent: a report on clinical cases. P R Health Sci J. 2004 Jun;23(2):115-8. [Abstract]

    • Riordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, González MJ, Mora EM, Miranda-Massari JR, Rosario N, Rivera A.

  • Cell membrane fatty acid composition differs between normal and malignant cell lines. P R Health Sci J. 2004 Jun;23(2):103-6. [Abstract]

    • Meng X, Riordan NH, Riordan HD, Mikirova N, Jackson J, González MJ, Miranda-Massari JR, Mora E, Trinidad Castillo W.

  • L-ascorbic acid represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60. J Cell Biochem. 2004 Oct 1;93(2):257-70. [Abstract]

    • Han SS, Kim K, Hahm ER, Lee SJ, Surh YJ, Park HK, Kim WS, Jung CW, Lee MH, Park K, Yang JH, Yoon SS, Riordan NH, Riordan HD, Kimler BF, Park CH, Lee JH, Park S.

  • Intravenous ascorbic acid: protocol for its application and use. P R Health Sci J. 2003 Sep;22(3):287-90. [Abstract]

    • Riordan HD, Hunninghake RB, Riordan NH, Jackson JJ, Meng X, Taylor P, Casciari JJ, González MJ, Miranda-Massari JR, Mora EM, Rosario N, Rivera A.

  • Prevention of venous thrombosis in long-haul flights with Flite Tabs: the LONFLITE-FLITE randomized, controlled trial. Angiology. 2003 Sep-Oct;54(5):531-9. [Abstract]

    • Cesarone MR, Belcaro G, Nicolaides AN, Ricci A, Geroulakos G, Ippolito E, Brandolini R, Vinciguerra G, Dugall M, Griffin M, Ruffini I, Acerbi G, Corsi M, Riordan NH, Stuard S, Bavera P, Di Renzo A, Kenyon J, Errichi BM.

  • Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis. P R Health Sci J. 2002 Dec;21(4):323-8. [Abstract]

    • Meng XL, Riordan NH, Casciari JJ, Zhu Y, Zhong J, González MJ, Miranda-Massari JR, Riordan HD.

  • Orthomolecular oncology: a mechanistic view of intravenous ascorbate’s chemotherapeutic activity. P R Health Sci J. 2002 Mar;21(1):39-41. [Abstract]

    • González MJ, Miranda-Massari JR, Mora EM, Jiménez IZ, Matos MI, Riordan HD, Casciari JJ, Riordan NH, Rodríguez M, Guzmán A.

  • Inhibition of human breast carcinoma cell proliferation by ascorbate and copper. P R Health Sci J. 2002 Mar;21(1):21-3. [Abstract]

    • González MJ, Mora EM, Miranda-Massari JR, Matta J, Riordan HD, Riordan NH.

  • Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours. Br J Cancer. 2001 Jun 1;84(11):1544-50. [Abstract]

    • Casciari JJ, Riordan NH, Schmidt TL, Meng XL, Jackson JA, Riordan HD.

  • Integrative medicine: a paradigm shift in medical education and practice. P R Health Sci J. 2000 Dec;19(4):389-92. [Abstract]

    • González MJ, Miranda-Massari JR, Mora EM, Cruzado NA, Jiménez I, Rosa M, Matos Vera MI, Santiago C, Román-Eyxarch MI, Rodríguez JR, Pérez Cortés C, Riordan NH, Riordan HD, Ricart CM.

  • The paradoxical role of lipid peroxidation on carcinogenesis and tumor growth: a commentary. Med Hypotheses. 1996 Jun;46(6):503-4. [Abstract]

    • González MJ, Riordan NH.

  • Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent. Med Hypotheses. 1995 Mar;44(3):207-13. [Abstract]

    • Riordan NH, Riordan HD, Meng X, Li Y, Jackson JA.

  • Improved microplate fluorometer counting of viable tumor and normal cells. Anticancer Res. 1994 May-Jun;14(3A):927-31. [Abstract]

    • Riordan HD, Riordan NH, Meng X, Zhong J, Jackson JA.

Neil Riordan 9-29-2011
www.neilriordan.net